← All trials
NCT01723696
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2012
- Primary completion
- Apr 1, 2016
- Completion date
- Nov 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 278
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Oregon Health and Science UniversityLead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- Oregon Health and Science UniversityOverall official - principal investigator
- Office of Dietary Supplements (ODS)Collaborator
- Oregon Health and Science UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.